Stanley Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
- Revenue Growth 82.94%
- Profit Growth 207.34%
- Ebitda 166.92%
- Net Worth 72.62%
- Total Assets 53.87%
About Stanley Medicare
Stanley Medicare Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2019 (Five years and ten months 14 days old ). Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 Cr.
Shatrughan and Sunita serve as directors at the Company.
Company Details
-
Location
New Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290DL2019PTC347925
-
Company No.
347925
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Mar 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Stanley Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shatrughan
|
Director | 28-Mar-2019 | Current |
|
Sunita
|
Director | 28-Mar-2019 | Current |
Financial Performance of Stanley Medicare.
Stanley Medicare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 82.94% increase. The company also saw a substantial improvement in profitability, with a 207.34% increase in profit. The company's net worth Soared by an impressive increase of 72.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stanley Medicare?
In 2023, Stanley Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Stanley Healthcare Private LimitedShatrughan is a mutual person
-
Milkweeds Biotech LlpShatrughan is a mutual person
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.75 Cr
- Hdfc Bank Limited : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2024 | Others | ₹7.50 M | Open |
| 25 Sep 2023 | Hdfc Bank Limited | ₹7.50 M | Open |
How Many Employees Work at Stanley Medicare?
Stanley Medicare has a workforce of 6 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stanley Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanley Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.